These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


443 related items for PubMed ID: 20542127

  • 1. Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease.
    Somoza R, Juri C, Baes M, Wyneken U, Rubio FJ.
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1530-40. PubMed ID: 20542127
    [Abstract] [Full Text] [Related]

  • 2. Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures.
    Ostergaard K, Jones SA, Hyman C, Zimmer J.
    Exp Neurol; 1996 Dec; 142(2):340-50. PubMed ID: 8934565
    [Abstract] [Full Text] [Related]

  • 3. Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats.
    Xiong N, Cao X, Zhang Z, Huang J, Chen C, Zhang Z, Jia M, Xiong J, Liang Z, Sun S, Lin Z, Wang T.
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1519-29. PubMed ID: 20542126
    [Abstract] [Full Text] [Related]

  • 4. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
    Bustos G, Abarca J, Bustos V, Riquelme E, Noriega V, Moya C, Campusano J.
    J Neurosci Res; 2009 Aug 01; 87(10):2308-18. PubMed ID: 19326433
    [Abstract] [Full Text] [Related]

  • 5. Rat mesenchymal stem cells increase tyrosine hydroxylase expression and dopamine content in ventral mesencephalic cells in vitro.
    Jin GZ, Cho SJ, Choi EG, Lee YS, Yu XF, Choi KS, Yee ST, Jeon JT, Kim MO, Kong IK.
    Cell Biol Int; 2008 Nov 01; 32(11):1433-8. PubMed ID: 18778785
    [Abstract] [Full Text] [Related]

  • 6. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA, Connor B, Tillerson JL, Schallert T, Bohn MC.
    Exp Neurol; 2000 Nov 01; 166(1):1-15. PubMed ID: 11031079
    [Abstract] [Full Text] [Related]

  • 7. Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases.
    Sadan O, Shemesh N, Cohen Y, Melamed E, Offen D.
    Isr Med Assoc J; 2009 Apr 01; 11(4):201-4. PubMed ID: 19603590
    [Abstract] [Full Text] [Related]

  • 8. Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury.
    Canudas AM, Pezzi S, Canals JM, Pallàs M, Alberch J.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):147-54. PubMed ID: 15790538
    [Abstract] [Full Text] [Related]

  • 9. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
    Andereggen L, Meyer M, Guzman R, Ducray AD, Widmer HR.
    Brain Res; 2009 Jun 18; 1276():39-49. PubMed ID: 19389387
    [Abstract] [Full Text] [Related]

  • 10. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B, Relova JL, Gallego R, Ben-Batalla I, Perez-Fernandez R.
    J Neurosci Res; 2009 Feb 15; 87(3):723-32. PubMed ID: 18816795
    [Abstract] [Full Text] [Related]

  • 11. Mesencephalic neural stem (progenitor) cells develop to dopaminergic neurons more strongly in dopamine-depleted striatum than in intact striatum.
    Nishino H, Hida H, Takei N, Kumazaki M, Nakajima K, Baba H.
    Exp Neurol; 2000 Jul 15; 164(1):209-14. PubMed ID: 10877931
    [Abstract] [Full Text] [Related]

  • 12. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
    Höglinger GU, Widmer HR, Spenger C, Meyer M, Seiler RW, Oertel WH, Sautter J.
    Exp Neurol; 2001 Jan 15; 167(1):148-57. PubMed ID: 11161602
    [Abstract] [Full Text] [Related]

  • 13. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease.
    Levy YS, Bahat-Stroomza M, Barzilay R, Burshtein A, Bulvik S, Barhum Y, Panet H, Melamed E, Offen D.
    Cytotherapy; 2008 Jan 15; 10(4):340-52. PubMed ID: 18574767
    [Abstract] [Full Text] [Related]

  • 14. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
    Porritt MJ, Batchelor PE, Howells DW.
    Exp Neurol; 2005 Mar 15; 192(1):226-34. PubMed ID: 15698637
    [Abstract] [Full Text] [Related]

  • 15. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo.
    Moses D, Drago J, Teper Y, Gantois I, Finkelstein DI, Horne MK.
    Neuroscience; 2008 Jun 23; 154(2):606-20. PubMed ID: 18472226
    [Abstract] [Full Text] [Related]

  • 16. Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture.
    Schulz TC, Noggle SA, Palmarini GM, Weiler DA, Lyons IG, Pensa KA, Meedeniya AC, Davidson BP, Lambert NA, Condie BG.
    Stem Cells; 2004 Jun 23; 22(7):1218-38. PubMed ID: 15579641
    [Abstract] [Full Text] [Related]

  • 17. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS, Tang LL, Zheng SS, Zhan RY, Zhou YQ, Goudreau J, Kaufman D, Chen AF.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):155-61. PubMed ID: 15790539
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
    Connor B, Kozlowski DA, Schallert T, Tillerson JL, Davidson BL, Bohn MC.
    Gene Ther; 1999 Dec 24; 6(12):1936-51. PubMed ID: 10637445
    [Abstract] [Full Text] [Related]

  • 19. Conditioned medium from human amniotic epithelial cells may induce the differentiation of human umbilical cord blood mesenchymal stem cells into dopaminergic neuron-like cells.
    Yang S, Sun HM, Yan JH, Xue H, Wu B, Dong F, Li WS, Ji FQ, Zhou DS.
    J Neurosci Res; 2013 Jul 24; 91(7):978-86. PubMed ID: 23633297
    [Abstract] [Full Text] [Related]

  • 20. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat.
    Blandini F, Cova L, Armentero MT, Zennaro E, Levandis G, Bossolasco P, Calzarossa C, Mellone M, Giuseppe B, Deliliers GL, Polli E, Nappi G, Silani V.
    Cell Transplant; 2010 Jul 24; 19(2):203-17. PubMed ID: 19906332
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.